Precipio (PRPO) Competitors $12.45 +1.15 (+10.18%) Closing price 07/3/2025 03:27 PM EasternExtended Trading$11.75 -0.70 (-5.62%) As of 07/3/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRPO vs. AKYA, OMIC, OPTX, AATC, CLIR, DAIO, MSAI, STAI, BNGO, and ASTCShould you be buying Precipio stock or one of its competitors? The main competitors of Precipio include Akoya Biosciences (AKYA), Singular Genomics Systems (OMIC), Syntec Optics (OPTX), Autoscope Technologies (AATC), ClearSign Technologies (CLIR), Data I/O (DAIO), MultiSensor AI (MSAI), ScanTech AI Systems (STAI), Bionano Genomics (BNGO), and Astrotech (ASTC). These companies are all part of the "measuring and control equipment" industry. Precipio vs. Its Competitors Akoya Biosciences Singular Genomics Systems Syntec Optics Autoscope Technologies ClearSign Technologies Data I/O MultiSensor AI ScanTech AI Systems Bionano Genomics Astrotech Akoya Biosciences (NASDAQ:AKYA) and Precipio (NASDAQ:PRPO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings. Do analysts rate AKYA or PRPO? Akoya Biosciences currently has a consensus target price of $2.51, suggesting a potential upside of 83.05%. Given Akoya Biosciences' stronger consensus rating and higher probable upside, equities research analysts plainly believe Akoya Biosciences is more favorable than Precipio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Akoya Biosciences 0 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Precipio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is AKYA or PRPO more profitable? Precipio has a net margin of -15.45% compared to Akoya Biosciences' net margin of -59.44%. Precipio's return on equity of -25.87% beat Akoya Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Akoya Biosciences-59.44% -487.85% -35.86% Precipio -15.45%-25.87%-17.93% Which has stronger earnings & valuation, AKYA or PRPO? Precipio has lower revenue, but higher earnings than Akoya Biosciences. Precipio is trading at a lower price-to-earnings ratio than Akoya Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAkoya Biosciences$81.67M0.84-$55.37M-$0.97-1.41Precipio$18.53M1.01-$4.29M-$2.07-6.01 Does the media prefer AKYA or PRPO? In the previous week, Akoya Biosciences' average media sentiment score of 0.00 equaled Precipio'saverage media sentiment score. Company Overall Sentiment Akoya Biosciences Neutral Precipio Neutral Which has more risk & volatility, AKYA or PRPO? Akoya Biosciences has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, Precipio has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Do institutionals and insiders have more ownership in AKYA or PRPO? 79.4% of Akoya Biosciences shares are held by institutional investors. Comparatively, 10.5% of Precipio shares are held by institutional investors. 7.3% of Akoya Biosciences shares are held by company insiders. Comparatively, 16.9% of Precipio shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryAkoya Biosciences beats Precipio on 7 of the 13 factors compared between the two stocks. Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRPO vs. The Competition Export to ExcelMetricPrecipioMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.22M$2.04B$5.56B$9.05BDividend YieldN/AN/A5.24%4.01%P/E Ratio-6.0135.8727.6120.24Price / Sales1.0115.98416.87118.48Price / CashN/A55.8836.8958.10Price / Book1.538.708.035.67Net Income-$4.29M-$62.39M$3.18B$249.21M7 Day Performance15.28%2.58%2.93%3.28%1 Month Performance9.26%3.01%3.75%5.55%1 Year Performance144.01%4.06%35.20%21.09% Precipio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRPOPrecipioN/A$12.45+10.2%N/A+149.0%$18.22M$18.53M-6.0160High Trading VolumeAKYAAkoya Biosciences2.1395 of 5 stars$1.29+2.4%$2.51+94.3%-35.7%$62.94M$81.67M-1.3390OMICSingular Genomics Systems0.377 of 5 stars$20.01flat$6.50-67.5%N/A$50.83M$2.91M-0.57220OPTXSyntec OpticsN/A$1.33+4.7%N/A-42.9%$46.59M$29.44M0.003AATCAutoscope TechnologiesN/A$7.25-3.1%N/A+18.1%$39.77M$12.89M8.2440CLIRClearSign Technologies1.7536 of 5 stars$0.58-7.0%$2.00+246.7%-33.1%$32.52M$3.60M-4.8110DAIOData I/O2.6039 of 5 stars$2.84-0.4%$4.00+40.8%+13.5%$26.33M$21.77M-9.79100Positive NewsGap UpMSAIMultiSensor AI2.7658 of 5 stars$0.52-18.5%$2.50+380.8%-60.9%$21.35M$7.40M0.0035STAIScanTech AI SystemsN/A$0.69-4.8%N/AN/A$18.57M$540K0.00N/AGap UpBNGOBionano Genomics1.3182 of 5 stars$3.27+2.2%$7.00+114.1%-90.1%$10.77M$30.78M-0.02300ASTCAstrotechN/A$5.96+1.9%N/A-37.1%$9.91M$1.66M-0.7110Positive News Related Companies and Tools Related Companies Akoya Biosciences Alternatives Singular Genomics Systems Alternatives Syntec Optics Alternatives Autoscope Technologies Alternatives ClearSign Technologies Alternatives Data I/O Alternatives MultiSensor AI Alternatives ScanTech AI Systems Alternatives Bionano Genomics Alternatives Astrotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRPO) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRPO Stock Alerts